FDABridge
← Balik sa blog
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

FDA Stories #016 β€” An Egyptian Dates Exporter's Prior Notice Had the Wrong FDA Registration Number

Bidhaa ilidai 'kuongeza nishati na kusaidia kazi ya kinga.' Hizo ni madai ya muundo/kazi. Bidhaa ilihitaji paneli ya Supplement Facts, si Nutrition Facts.

Koponan ng FDABridgeβ€’Ene 1, 2026β€’3 min na mabasa

A matcha company in Uji, Kyoto, produced a premium ceremonial-grade matcha powder that they sold in Japan as a traditional tea. When they expanded to the US, their American distributor suggested adding health claims to the marketing: 'Boosts energy naturally,' 'Supports immune function,' 'Rich in antioxidants for cellular health.'

The product was labeled as a food with a Nutrition Facts panel. The marketing materials β€” on the website, on Amazon, and on shelf talkers β€” contained structure/function claims.

Tatizo

Under US law, a product that makes structure/function claims β€” claims about how a substance affects the structure or function of the body β€” is either a dietary supplement (if it contains a dietary ingredient and is intended for ingestion) or a drug (if the claims go further into disease treatment). A conventional food cannot make structure/function claims without triggering reclassification. 'Boosts energy' and 'supports immune function' are structure/function claims that pushed the matcha from the food category into the dietary supplement category.

As a dietary supplement, the product needed a Supplement Facts panel (not Nutrition Facts), the required disclaimer ('This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease'), a structure/function claim notification filed with the FDA within 30 days of first marketing, and facility registration under the dietary supplement CGMP requirements of 21 CFR Part 111.

Tulifanya nini

The company had two paths. They could remove all structure/function claims and sell the matcha as a conventional food β€” which would require only the standard food facility registration and a Nutrition Facts panel. Or they could keep the claims and comply with dietary supplement regulations. They chose to sell the matcha as a conventional food in retail stores (no health claims) and as a dietary supplement through their e-commerce channel (with compliant claims and labeling). Two SKUs. Two labels. Two regulatory pathways from the same facility.

If your product is a tea, powder, extract, or botanical and you want to make health-related claims in the US β€” you are almost certainly selling a dietary supplement, not a food. The labeling, registration, and compliance requirements are different. Get it right before you launch. fdabridge.com/contact.

Kailangan mo ng tulong sa susunod?

Kailangan ng tulong sa pagpili ng serbisyo?

Ihambing ang mga serbisyo at piliin ang tamang filing path para sa iyong produkto.

Mas marami pang mabasa

Mga kaugnay na artikulo

Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Alama za Uwekaji Lebo wa Kifaa cha Matibabu: Watengenezaji wa Kigeni Lazima Wajue Nini kwa Kuingia Soko la Marekani

Abr 28, 2026

Uwekaji lebo wa kifaa cha matibabu nchini Marekani unahitaji alama maalum kwa mawasiliano sahihi. Watengenezaji wa kigeni lazima waelewe viwango vya alama vinavyokubalika na FDA kabla ya kusafirisha vifaa kwenda soko la Marekani.

Magbasa pa β†’
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Usajili wa vifaa vya matibabu kwa watengenezaji wa kigeni: Mwongozo wa Mfumo wa Udhibiti wa Marekani

Mar 26, 2026

Watengenezaji wa vifaa vya matibabu wa kigeni lazima waandikishe taasisi zao, orodha ya vifaa vyao, na kulingana na darasa la vifaa kupata idhini ya FDA au idhini kabla ya kusambaza nchini Marekani.

Magbasa pa β†’
Pangunahing Pangunahing Pangunahing Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Pangunahang Panguna

Maswali Kumi ya Kujiuliza Kabla ya Kuajiri Mshauri wa FDA

May 24, 2026

Kuchagua mtoa huduma wa kufuata sheria za FDA ni uamuzi muhimu. Maswali hayo kumi huwasaidia wazalishaji wa kigeni kuwatenganisha washauri wenye uwezo na wale watakaotokeza matatizo ambayo hawawezi kuyatatua.

Magbasa pa β†’